[Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
Hanyu Zheng(Jiangsu Institute of Parasitic Diseases), W F Piessens, Liqun Luo(Sun Yat-sen University), Xiaokang Chen(Army Medical University), S H Wang, Z H Tao, Wenli Cheng, Su-Fen Cheng, Y M Ye
PubMed
January 1, 1993
Cited by 0
Related Papers
Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
|Circulation|2024|62
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
|Clinical Cancer Research|2019|51
Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells
|Cancer Immunology Research|2018|29
Mesenchymal stem cells participate in oral mucosa carcinogenesis by regulating T cell proliferation
|Clinical Immunology|2018|23
Research progress of freezing processes and devices for fresh meat products
|International Journal of Refrigeration|2024|17